83

DAFTAR PUSTAKA

Adnan, Z.A. 2012. Clinical Manifestation and Assesment of Systemic Lupus

Erythematosus, hlm. 1-17. dalam : Hermawan, G., Adnan, Z.A., Purwanto,
B., Harmono, T., Soewoto, S (edt). Kumpulan Makalah Simposium
Indonesian Rheumatology Association Cabang Surakarta. UNS Press,
Surakarta.
Banchereau, J. dan Pascual, V. 2006. Type I Interferon in Systemic Lupus
Erythematosus and Other Autoimmune Disease. Immunity, vol. 25, hlm.
383- 393.
Bertsias, G., Cervera, R., Boumpas, D.T. 2012. Systemic Lupus Erythematosus:
Pathogenesis, Clinical Manifestations, And Diagnosis, hlm. 476-505. in :
Cervera, R., Espinosa, G., D’Cruz, D (edt). Eular Textbook of Rheumatic
Disease.
Bevra HH. 2013. The Pathogenesis of SLE. In : Wallace DJ, Bevra HH. DUBOIS
Lupus Erythematosus and Related Syndromes. Eighth Edition.
Philadelpia : Saunders. Pp : 25-35
Black, S., Kushner, I., Samols, D. 2004. C-Reactive Protein. Journal of Biological
Chemistry, vol. 47, no. 279, hlm. 48487-48490.
Calvani, N., Caricchio, R., Tucci, M., Sobel, E., Silvestris, P., Tartaglia, P.,
Richards, H.B. 2007. Induction of Apoptosis by the Hydrocarbon Oil
Pristane: Implications for Pristane-Induced Lupus. The Journal of
Immunology, no. 175, hlm. 4777-4782.
Chen, J., Wu, M., Wang, J., Li, X. 2015. Immunoregulation of NKT Cells in
Systemic Lupus Erythematosus. Journal of Immunology Research, vol.
2015, no. 20673, hlm. 1-8.
Choi, J., Kim, S.T., Craft, J. 2012. The Pathogenesis of Systemic Lupus
Erythematosus : an Update. Current Opinion in Immunology, no. 24, hlm.
651-657.
Comte, B. H., Karampetsou, M. P., Tsokos, G. C. 2015. T cells as a therapeutic
target in SLE. Journal Lupus, vol. 2015, no. 24, hlm. 351-363.
Colicchio, C., Ohashi, T., Brunson, A., Sloboda, C., Emrani, J., Idassi, J., Jesmin,
S., and Mowa, C. (2015) Moringa oleifera's whole methanolic extract
attenuates levels of pro-inflammatory markers in the cervix of preterm
labor mice models. The FASEB Journal 29 (1) Supplement 721.42.
Dharmezier dan Bawazier, L.A. 2014. Diagnosis Dan Penatalaksanaan Nefritis
Lupus. hlm. 3378-85. Dalam : Simadibrata, M., et al., (editors). Buku Ajar
Ilmu Penyakit Dalam Jilid III Edisi VI. Jakarta : Interna PublishingFK UI.
Fatima, N. & Fatima, S.J., 2016. Pharmacological Screening For Anti-Arthritic
Activity Of Moringa Oleifera. , Asian J Pharm Clin Res. Vol 9(3), pp.106–
111.
 84

Fagnoni, F. F., Vescovini, R. and Passeri, G. (2000). Shortage of circulating naive

CD8+ T cells provides new insights on immunodeficiency in aging. Blood.
95: 2860-2868.
Fathir A, Rifai M, Widodo, 2014, Aktivitas Ekstrak Daun Kelor Terhadap Sel-T
Helper dan Sel-T Sitotoksik pada Mencit yang Diinfeksi Salmonella thypi,
Jurnal veteriner. p 114-122.
Ferreira P, Araujo EJ, Silva JN, Freitas RM, Costa ND, Oliveira SF. et al., Safety
and Efficacy of Moringa oleifera Lamarck ( 1785 ) — Therapeutic and
Toxicological Properties. World largest Science , Technology & Medicine
Open Access book publisher.p179-205.
Fink MP. 2014. Animal models of sepsis. Virulence. 2014 Jan 1; 5(1): 143–153.
Gaikwad, S.B., Mohan, G.K. & Reddy, K.J., 2011.International Journal of
Pharmacy and Pharmaceutical Siences. Vol 3 (5), pp.426–30.
Ghonemy TA, Salimb EM, Al-Hendib YA, El Okely A. 2010. T-helper 1 Immune
Response in Systemic Lupus Erythematosus and its Relation to Disease
Activity. Arab Journal of Nephrology and Transplantation. 2(3):15-20
Guntur A. 2006. Perspektif masa depan Imunologi-Infeksi. UNS Press, Solo.
Hal:172-6.
Hahn, B.H. 2013. The Pathogenesis of SLE, hlm. 25-35. in : Wallace, D.J., Hahn,
B.H (edt). Dubois' Lupus Erythematosus and Related Syndromes. Eighth
Edition. Saunders: Philadelpia.
Hassan A., Badawy M. A., Elmasry E., Balata M., Habib A. 2014. Serum level of
Interleukin -17 in Systemic lupus erythematosus: clinical associations with
disease activity and lupus nephritis. Indian Journal Of Applied Research.
Volume : 4(10).
He, Q., Wan, C., Li, G. 2007. Concise Review: Multipotent Mesenchymal
Stromal Cells in Blood. Stem cells, vol. 25, no. 1, hlm. 69 – 77.
Isbagio H, Albar Z, Kasjmir YI, Setyohadi B. 2006. Lupus Eritematosus Sistemik.
Buku Ajar Ilmu Penyakit Dalam Jilid II, Edisi IV, hal: 1224-1230.
Jianxin LU, Bonnie KC, Cheukchun S. 2009. Update on The Role of T Cell
Subset in the pathogenesis of Sistemic Lupus Erimatosus. Journal of
China Clinical Medicine N0 4/7/2009.
Lan HY. 2011. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.
Int J Biol Sci. 7(7):1056-67.
Lawrence, T. (2009). The nuclear factor NF-kappaB pathway in inflammation.
Cold Spring Harb Perspect Biol 1(6), a001651 PubMed
http://dx.doi.org/10.1101/cshperspect.a001651
Lech M, Anders HJ. 2013. The pathogenesis of lupus nephritis. J. Am. Soc.
Nephrol.  24:1357–1366.
Lee, R.H., Pulin, A.A., Seo, M.J., Kota, D.J., Ylostalo, J., Larson, B.L., Prieto,
L.S., Delafontaine, P., Prockop, D.J. 2009. Intravenous hMSCs Improve
 85

Myocardial Infarction in Mice Because Cells Embolized in Lung Are

Activated to Secrete the Anti-Inflammatory Protein TSG-6. Cell Stem Cell,
vol. 5, no. 1, hlm. 54 – 63.
Loeffler I, Wolf G. 2013. Transforming growth factor-β and the progressionof
renal disease. Nephrol Dial Transplant 0: 1–9.
Mahardika M .2017. Efek Induksi Pristan Pada Mencit Balb/C Terhadap
Progresivitas Artritis Melalui Regulasi Sel Th1, Th2, Th17 Dan Treg.
Universitas Brawijaya.
Maroz N, Segal MS. 2013. Lupus nephritis and end-stage kidney disease. Am. J.
Med. Sci. 346:319–323.
Mocarzel,L.O.C., Lanzieri, P.G., Montes, R.A., Gismondi, R.A.O.C., Mesquita,
C.T. 2015. Systemic Lupus Erythematosus: Review of Cardiovascular
Aspects. Internacional Journal of Cardiovascular Science,vol. 2015, no.
28(3), hlm. 251-261.
Musai, M. 2010. Terapi Lupus Eritematosus Sistemik dengan Penghambatan
Kostimulasi Sel T. Majalah Kedokteran Indonesia, vol. 60, no. 10, hlm. 1-
6.
Nalbandian A., Crispín J. C., Tsokos G. C. 2009. Interleukin-17 and systemic
lupus erythematosus: current concepts. Clinical and Experimental
Immunology.157: 209–215.
Nowling TK, Gilkeson GS. 2010.Mechanisms of tissue injury in lupus nephritis.
Arthritis Res Ther. 13(6):250
Peliçari KdeO, Postal M, Sinicato NA, Peres FA, Fernandes PT, Marini R, et al.
2015.Serum interleukin-17 levels are associated with nephritis in
childhood-onset systemic lupuserythematosus.Clinics (Sao Paulo).
70(5):313-7.
Perhimpunan Reumatologi Indonesia. 2018. Rekomendasi Perhimpunan
Reumatologi Indonesia Untuk Diagnosis dan Pengelolaan Lupus
Eritematosus Sistemik. Perhimpunan Reumatologi Indonesia.
Purwanto B. 2010. Kajian ekspresif gf-β1, mmp-9, kolagentipe-I, kolagentipe-IV,
glomerulosklerosis, interstisial fibrosis, albuminuri pada kejadian
nefrotoksik doxorubicin dan nefr oprotektif pentoxifylin dengan hewan
coba mencit galur swiss jantan. Disertasi. Program Pascasarjana.
UniversitasAirlangga. Surabaya.
Rabbani MA, Habib HB, Islam M, Ahmad B, Majid S, Saeed W, et al. 2009.
Survival analysis and prognostic indicators of systemic
lupuserythematosus in Pakistani patients. Lupus;18, 848–855
Rachmawati, I. & Rifa, M., 2014. In Vitro Immunomodulatory Activity of
Aqueous Extract of Moringa oleifera Lam . Leaf to the CD4 + , CD8 + and
B220+ Cells in Mus musculus. J.Exp.Life Sci. 4(1).
Ray, S.J., Wolf, T.J. & Mowa, C.N., 2017. Moringa oleifera and inflammation : a
mini-review of its effects and mechanisms. , pp.317–330
 86

Reeves, W.H., Lee, P.Y., Weinstein, J.S., Satoh, M., Lu, L. 2009. Induction of
Autoimmunity by Pristane and Other Naturally Occurring Hydrocarbons.
Trends in Immunology, vol. 30, no. 9, hlm. 455–464.
Rhodes, B., Furnrohr, B.G., Vyse, T.J. 2011. C-Reactive Protein in
Rheumatology: Biology and Genetics. Nature Reviews Rheumatology,
no. 7, hlm. 282-289.
Robbins dan Cotran. 2005. General Pathology: Bassic Pathology Dissease.
Jakarta: EGC. hlm. 20-43.
Rottman JB, Willis CR. 2010. Mouse models of systemic lupus erythematosus
reveal a complex pathogenesis. Vet Pathol.47(4):664-76
Sandra HS, Gracia JL, Rouzaut A, Sanmamed MF,Le Bon A, Melero I. 2011.
Direct Effects of Type I Interferons on Cells of the Immune System.
American Association for Cancer. 10.1158/1078-0432
Sastroasmoro S, Ismail S. 2011. Dasar-Dasar MetodologiPenelitianKlinis.
Jakarta :Sagungseto. h 35-40.
Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, et al. 2015.
Function of the Th17/interleukin-17A immune response in murine lupus
nephritis.Arthritis Rheumatol. 67:475–487. 
Spelman, K., Burns, J., Nichols, D., Winters, N., Ottersberg, S. and Tenborg, M.
(2006). "Modulation of cytokine expression by traditional medicines: a
review of herbal immunomodulators". Alternative Medicine reviews, 11:
128-150.
Srivastava S, Koch MA, Pepper M, Campbell DJ. 2014. Type I interferons
directly inhibit regulatory T cells to allow optimal antiviral T cell
responses during acute LCMV infection. Journal of Experimental
Medicine. vol. 211 no. 5 961-974.
Suarjana, I.N. 2014. Imunopatogenesis Lupus Eritematosus Sistemik, hlm. 3331-
3345. dalam : Simadibrata M., Syam A.F., Setiati S., Setyohadi B., Alwi I
(edt). Buku Ajar Ilmu Penyakit Dalam Jilid III. Edisi VI. Interna
Publishing FK UI, Jakarta.
Summers SA, Odobasic D, Khouri MB, Steinmetz OM, Yang Y, Holdsworth SR,
Kitching AR.2014. Endogenous interleukin (IL)-17A promotes pristane-
induced systemic autoimmunity and lupus nephritis induced by
pristane.ClinExp Immunol. 176(3):341-50.
Tamaki K, Seiya O, Takashi A. 1994. TGF-β in Glomerulosklerosis and
Interstitial Fibrosis, of Andriamicyn Neprhopaty. Kidney International
45:525 – 536.
Tan, W.S., Arulselvan, P., Karthivashan, G., and Fakurazi, S. (2015). Moringa
oleifera flower extract suppresses the activation of inflammatory mediators
in lipopolysaccharide-stimulated RAW 264.7 macrophages via NF-κB
pathway. Mediators Inflamm. 2015, 720171 PubMed
http://dx.doi.org/10.1155/2015/720171.
 87

Tsokos, G.C. 2011. Mechanism of Disease Systemic Lupus Erythematosus. New

England Journal of Medicine, vol. 365, no. 22, hlm. 2110-2121.
Vallance P, Leiper J. 2004. Cardiovaskular biology of the Asymetric
Dimethylarginine : Dimethylarginine Dimethylamino Hydrolase Pathway.
Arterioskler Thromb Vasc Biol 1023-1030.
Vincent F. B., Northcott M., Hoi A., Mackay F., Morand E. F. 2013. Clinical
associations of serum interleukin-10 in systemic lupus erythematosus
Clinical associations of serum interleukin-10 in systemic lupus
erythematosus. Arthritis Research & Therapy. 15:R97.
Wang, C., Cheng, L., Xu, H., Liu, Z. 2012. Towards Whole-Body Imaging at the
Single Cell Level Using Ultra-Sensitive Stem Cell Labeling with Oligo-
Arginine Modified Upconversion Nano Particles. Biomaterials, vol. 33,
no. 19, hlm. 4872 – 4881.
Waterman, C., Rojas-Silva, P., Tumer, T.B., Kuhn, P., Richard, A.J., Wicks, S.,
Stephens, J.M., Wang, Z., Mynatt, R., Cefalu, W., and Raskin, I. (2015).
Isothiocyanate-rich Moringa oleifera extract reduces weight gain, insulin
resistance, and hepatic gluconeogenesis in mice. Mol Nutr Food Res 59
(6), 1013–1024 PubMed http://dx.doi.org/10.1002 /mnfr.201400679.
Yap, D.Y.H. dan Lai, K.N. 2010. Cytokines and Their Roles in Pathogenesis of
Systemic Lupus Erythematosus: From Basics to Recent Advances. Journal
of Biomedicine and Biotechnology, hlm. 1-10.